Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-07
1996-03-12
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424450, 424489, 424490, 514921, 606151, A61K 31505
Patent
active
054986133
ABSTRACT:
Compositions and methods for prevention of adhesion formation, whereby an effective amount of at least one compound selected from dipyridamole and analogs thereof is administered as active agent for a period of time sufficient to permit tissue repair. The active agent is preferably administered in conjunction with a delivery vehicle (e.g., microcapsules, microspheres, lipid-based systems, viscous instillates and absorbable mechanical barriers) useful for maintaining local concentrations of the compound at an effective level.
REFERENCES:
patent: 4346108 (1982-08-01), Singer
patent: 4538596 (1985-09-01), Colasante
patent: 4889722 (1989-12-01), Sheffield et al.
patent: 4911926 (1990-03-01), Henry et al.
patent: 4937254 (1990-06-01), Sheffield et al.
patent: 5002551 (1991-03-01), Linsky et al.
patent: 5246715 (1993-09-01), Orevi et al.
patent: 5364622 (1994-11-01), Franz et al.
Aznar-Salatti, J. et al., "Dipyridamole induces changes in the thrombogenic properties of extracellular matrix generated by endothelial cells in culture," Thrombosis Research 64, 341-353 (1991).
Brereton et al., "Effect of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate," Biochem. J. 120, 709-718 (1970).
Bamford, C. H. et al., "Polymeric inhibitors of platelet aggregation. II. Copolymers of dipyridamole and related drugs with N-vinylpyrrolidone," Biochim. Biophys. Acta 924, 38-44 (1987).
Bjornsson, T. D. et al., "Effective antiplatelet drug concentrations in experimental arterial thromboembolism," Thrombosis Research 48, 337-348 (1987).
Boeynaems, J. M. et al., "Dipyridamole and vascular prostacyclin production," Biochemical Pharmacol. 35, 2897-2902 (1986).
Brozna, J. P. et al., "Dipyridamole inhibits O.sub.2 release and expression of tissue factor activity by peripheral blood monocytes stimulated with lipopolysaccharide," Thrombosis Research 60, 141-156 (1990).
Bult, H. et al., "Dipyridamole potentiates platelet inhibition by nitric oxide," Thrombosis & Haemostasis 66, 343-349 (1991).
Chan, T. C. K. et al. "Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patients," Cancer Research 48, 215-218 (1988).
Chatelut, E. et al., "A slow-release methotrexate formulation for intrathecal chemotherapy," Cancer Chemother. Pharmacol. 32, 179-182 (1993).
Colli, S. & Tremoli, E., "Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: adenosine-dependent and adenosine-independent mechanisms," J. Lab. Clin. Med. 118, 136-145 (1991).
Constantini, V. et al., "Increased prostacyclin production from human veins by dipyridamole: an in vitro and ex vivo study," Biomed. Biochim. Acta 49, 263-271 (1990).
Czejka, M. J. et al., "Clinical pharmacokinetics of 5-fluorouracil," Drug Res. 43, (1993).
Dawicki, D. D. et al., "Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine," Biochemical Pharmacol. 34, 3965-3972 (1985).
diZerega, G. S. & Rodgers, K., "Fibroblasts and Tissue Repair Cells," in The Peritoneum, diZerega, G. S. & Rodgers, K. E., eds., Springer-Verlag, New York, pp. 122-127, 130-144 (1992).
diZerega, G. S. & Rodgers, K., "Peritoneal Closure," in The Peritoneum, diZerega, G. S. & Rodgers, K. E., eds., Springer-Verlag, New York, pp. 278-280 (1992).
diZerega, G. S. & Rodgers, K. E., "Prevention of Postoperative Adhesions," in The Peritoneum, diZerega, G. S. & Rodgers, K. E., eds., Springer-Verlag, New York, pp. 307-369 (1992).
Durante, W. et al., "Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells," Am. J. Physiol. 261, H2024-30 (1991).
Durante, W. et al., "Plasmin potentiates induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells," Am. J. Physiol. 264, H617-24 (1993).
Doody, K. J. et al., "Recombinant tissue plasminogen activator reduces adhesion formation in a rabbit uterine horn model," Fertil. Steril. 51, 509-512 (1989).
Elkins, T. E., "Can a Pro-Coagulant Substance Prevent Adhesions?" in Treatment of Post-Surgical Adhesions, diZerega, G. S. et al., eds., Wiley-Liss, New York, pp. 103-112 (1990).
Fregnan, G. B. & Berte, F., "Enhancement of specific biological activity of dipyridamole by complexation with .beta.-cyclodextrin," Pharmacology 40, 96-102 (1990).
Golan, et al., "The effect of prostaglandins and aspirin--an inhibitor of prostaglandin synthesis--on adhesion formation in rats," Human Reproduction 6, pp. 251-254 (1991).
Hasday, J. D. et al., "Dipyridamole stimulates urokinase production and suppresses procoagulant activity of rabbit alveolar macrophages: a possible mechanism of antithrombotic action," Blood 69, 660-667 (1987).
Herschlag, A. et al., "The effect of interleukin-1 on adhesion formation in the rat," Am. J. Obstet. Gynecol. 165, 771-4 (1991).
INTERCEED(TC7) Adhesion Barrier Study Group, "Prevention of postsurgical adhesions by INTERCEED(TC7), an absorbable adhesion barrier: a prospective, randomized multicenter clinical study," Fertility and Sterility 51, 933-938 (1989).
Kim, T. K. et al., "Extended-release formulation of morphine for subcutaneous administration," Cancer Chemother. Pharmacol. 33, 187-190 (1993).
LeVraux, V. et al., "Inhibition of human monocyte TNF production by adenosine receptor agonists," Life Sciences 52, 1917-1924 (1993).
Lichtner, R. B. et al., "The pyrimido-pyrimidine derivatives RA233 and RX-RA85 affect cell cycle distribution of two murine tumour cell lines," Eur. J. Cancer Clin. Oncol. 25, pp. 945-951 (1989).
McBride, W. H. et al., "Effect of Interleukin 1, inflammation, and surgery on the incidence of adhesion formation and death after abdominal irradiation in mice," Cancer Research 49, 169-173 (1989).
Mammen, E. F., "An overview of dipyridamole," Thrombosis Research Supplement XII, 1-3 (1990).
Stozek et al., "Bioverfugbarkeit von Dipyridamol in Form von Liposomen", Pharmazie 41 H.9, pp. 645-647 (1986).
Nitelius et al., "Pharmacokinetic interaction of acetylsalicylic acid and dipyridamole", British Journal of Clinical Pharmacology, vol. 19, Issue 3, pp. 379-383 (Mar. 1985).
Nishmura et al., "Ibuprofen in the Prevention of Experimentally Induced Postoperative Adhesions", The American Journal of Medicine, pp. 102-106 (Jul. 13, 1984).
Mills et al., "The Influence on Platelet Aggregation of Drugs That Affect the Accumulation of Adenosine 3':5'-Cyclic Monophosphate in Platelets", Bioch., vol. 121, pp. 185-196 (1971).
Rodgers, "Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in the Treatment of Postsurgical Adhesion", Treatment of Post Surgical Adhesions, Published by Wiley-Liss, Inc., pp. 119-129 (1990).
Isonishi et al., "Phase I and Pharmacokinetic Trial of Intraperitoneal Etoposide in Combination With the Multidrug-Resistance-Modulating Agent Dipyridamole", Journal of the National Cancer Institute, vol. 83, Issue 9, pp. 621-626 (May 1, 1991).
Newell et al., "The Effect of the Nucleoside Transport Inhibitor Dipyridamole on the Incorporation of [3H] Thymidine in the Rat", Biochemical Pharmacology, vol. 35, Issue 21, pp. 3871-3877 (Nov. 1, 1986).
Rodgers et al., "Effects of Tolmetin Sodium Dihydrate on Normal and Postsurgical Peritoneal Cell Function", International Journal Immunopharmac., vol. 10, No. 2, pp. 111-119 (1988).
Sakuma et al., "Dipyridamole Potentiates the Anti-Aggregating Effect of Endothelium-Derived Relaxing Factor", Thrombosis Research Supplement XII, pp. 87-90 (1990).
Saniabadi et al., "Effect of Dipyridamole Alone and in Combination With Aspirin on Whole Blood Platelet Aggregation, PGI Generation, and Red Cell Deformability Ex Vivo in Man", Cardiovascular Research, vol. 25, Issue 3, pp. 177-183 (Mar. 1991).
Soderback et al., "Effect of Dipyridamole-Like Compound (R-E 244) on Aggregation and Cyclic AMP Accumulation in Human Platelets", Thrombosis Research, vol. 64, No. pp. 355-362 (1991).
Stringer et al., "Disposition of Oral Dipyridamole in Patients Undergoing Thallium 201 Myocardial Imaging", Pharmacotherap
diZerega Gere S.
Rodgers Kathleen E.
Griffin Ronald W.
The University of Southern California
LandOfFree
Dipyridamole and analogs thereof in preventing adhesion formatio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dipyridamole and analogs thereof in preventing adhesion formatio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipyridamole and analogs thereof in preventing adhesion formatio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2100111